Medical Foods Market Is Anticipated To Witness Growth At A Estimated CAGR: 6.9% Till 2025
“The key factors driving of the Medical Foods Market expansion include growing nutritional deficiency due to diseased conditions, increase in prevalence of chronic diseases, and rise in global geriatric population.�
The global medical foods market is expected to reach a value of USD 24.4 billion by 2025, according to a new report by Grand View Research, Inc. The medical foods market is anticipated to grow at a CAGR of 6.9% over the forecast period. The key factors supporting expansion include the growing awareness about medical foods, improvement in patient healthcare outcomes, rise in prevalence of several chronic diseases, increase in malnutrition, and continuous innovation. Access Full Research Report on Global Medical Foods Market: http://www.grandviewresearch.com/industry-analysis/medical-foods-market The use of medical foods to assist the patients during the treatment of chronic diseases has been a prevalent practice. However, lack of awareness about the proper usage, quality concerns, and overlapping claims about benefits associated due to the usage of medical foods have restricted the growth of medical foods market.
Follow Us:
The difference between functional foods, dietary supplements, and medical foods is still not clear for several healthcare practitioners. Therefore, errors in prescription or use of substitute products is a major trend observed in the market. Furthermore, the regulatory uncertainty pertaining to the classification of medical foods as a separate category has also affected the market growth. The prevalence of chronic diseases such as diabetic neuropathy, Alzheimer’s, Attention Deficit Hyperactivity Disorder (ADHD), and several metabolic diseases is increasing rapidly The risk of neuropathy significantly increases with increase in age, changes in diet, and adoption of an unhealthy lifestyle. Some of the symptoms usually associated with neuropathy include numbness, tingling, and pain in the feet, arms, & legs. Furthermore, some of the key products used to treat this condition include Percura capsules, METANX, and Foltanx. The growing number of patients with Alzheimer’s disease is also increasing rapidly. As per the estimates published by the Alzheimer’s Society, in the U.S., an estimated 5.4 million Americans across all ages are suffering from this disease. On further analysis of the data, it is observed that nearly 5.2 million people are aged 65 and above. Thus, rise in the geriatric population is also a major factor driving the medical foods market. Further key findings from the study suggest:
In 2015, oral route held the highest share as majority of the products are administered through the oral feeding
In 2015, powders category accounted for nearly 79% of the market share
In 2015, diabetic neuropathy was the largest application with a share of 34.3% owing to growing awareness about nutritional requirements during the treatment of chronic diseases
Asia Pacific is expected to lead the growth with a CAGR of 7.8% from 2016 to 2025
Some of the key players are Danone; Nestlé; Abbott; Targeted Medical Pharma Inc.; Primus Pharmaceuticals Inc.; Mead Johnson & Company, LLC.; and Fresenius Kabi AG.
Follow Us:
Grand View Research has segmented the medical foods market by route of administration, by product, by application, and by region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare Table of Content of Global Transcatheter Pulmonary Valve Market Research Report: Chapter 1 Research Methodology 1.1 Information Procurement 1.1.1 Purchased database: 1.1.2 GVR’s internal database 1.2 Primary Research 1.2.1 List of primary sources include: Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Medical Foods Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Growing prevalence of cancer 3.2.2 Increasing prevalence of chronic diseases 3.3 Market Restraint Analysis 3.3.1 Lack of awareness 3.3.2 Uncertainty in regulatory framework 3.4 Penetration & Growth Prospect Mapping 3.5 Medical Foods Market- SWOT Analysis, By Factor (Political & Legal, Economic & Technological)
Follow Us:
3.6 Industry Analysis - Porter’s Chapter 4 Medical Foods: Route of Administration Estimates & Trend Analysis 4.1 Medical Foods Market: Route of Administration Movement Analysis 4.2 Oral 4.2.1 Oral market estimates and forecasts, 2014 - 2025 (USD Million) 4.3 Enteral 4.3.1 Enteral market estimates and forecasts, 2014 - 2025 (USD Million) Chapter 5 Medical Foods: Product Estimates & Trend Analysis 5.1 Medical Foods Market: Product Movement Analysis 5.2 Pills 5.2.1 Pills market estimates and forecasts, 2014 - 2025 (USD Million) 5.3 Powder 5.3.1 Powder market estimates and forecasts, 2014 - 2025 (USD Million) 5.4 Others 5.4.1 Other products market estimates and forecasts, 2014 - 2025 (USD Million) Chapter 6 Medical Foods: Application Estimates & Trend Analysis 6.1 Medical Foods Market: Application Movement Analysis 6.2 Diabetic Neuropathy 6.2.1 Diabetic neuropathy market estimates and forecasts, 2014 - 2025 (USD Million) 6.3 ADHD 6.3.1 ADHD market estimates and forecasts, 2014 - 2025 (USD Million) 6.4 Depression 6.4.1 Depression market estimates and forecasts, 2014 - 2025 (USD
Follow Us:
Million) 6.5 Alzheimer's Disease 6.5.1 Alzheimer's disease market estimates and forecasts, 2014 - 2025 (USD Million) 6.6 Nutritional Deficiency 6.6.1 Nutritional deficiency market estimates and forecasts, 2014 2025 (USD Million) 6.7 Others 6.7.1 Other application market estimates and forecasts, 2014 - 2025 (USD Million) Chapter 7 Medical Foods: Regional Estimates & Trend Analysis, by Route of Administration, Product, and Application 7.1 Medical Foods Market Share by Region, 2014 & 2024 7.2 North America 7.2.1 North America medical foods market estimates and forecasts, 2014 - 2025 (USD Million) 7.2.2 U.S. 7.2.2.1 U.S. medical foods market estimates and forecasts, 2014 2025 (USD Million) 7.2.3 Canada 7.2.3.1 Canada medical foods market estimates and forecasts, 2014 - 2025 (USD Million) 7.3 Europe 7.3.1 Europe medical foods market estimates and forecasts, 2014 2025 (USD Million) 7.3.2 Germany 7.3.2.1 Germany medical foods market estimates and forecasts,
Follow Us:
2014 - 2025 (USD Million) 7.3.3 UK 7.3.3.1 UK medical foods market estimates and forecasts, 2014 2025 (USD Million) 7.4 Asia Pacific 7.4.1 Asia Pacific medical foods market estimates and forecasts, 2014 - 2025 (USD Million) 7.4.2 Japan 7.4.2.1 Japan medical foods market estimates and forecasts, 2014 2025 (USD Million) 7.4.3 China 7.4.3.1 China medical foods market estimates and forecasts, 2014 2025 (USD Million) 7.5 Latin America 7.5.1 Latin America medical foods market estimates and forecasts, 2014 - 2025 (USD Million) 7.5.2 Brazil 7.5.2.1 Brazil medical foods market estimates and forecasts, 2014 2025 (USD Million) 7.5.3 Mexico 7.5.3.1 Mexico medical foods market estimates and forecasts, 2014 - 2025 (USD Million) 7.6 MEA 7.6.1 MEA medical foods market estimates and forecasts, 2014 - 2025 (USD Million) 7.6.2 South Africa 7.6.2.1 South Africa medical foods market estimates and forecasts,
Follow Us:
2014 - 2025 (USD Million) Chapter 8 Competitive Landscape 8.1 Company Profiles 8.1.1 Danone 8.1.1.1 Company overview 8.1.1.2 Financial performance 8.1.1.3 Product benchmarking 8.1.1.4 Strategic initiatives 8.1.2 Nestle 8.1.2.1 Company overview 8.1.2.2 Financial performance 8.1.2.3 Product benchmarking 8.1.2.4 Strategic initiatives 8.1.3 Abbott 8.1.3.1 Company overview 8.1.3.2 Financial performance 8.1.3.3 Product benchmarking 8.1.3.4 Strategic initiatives 8.1.4 Targeted Medical Pharma 8.1.4.1 Company overview 8.1.4.2 Financial performance 8.1.4.3 Product benchmarking 8.1.4.4 Strategic initiatives 8.1.5 Primus Pharmaceuticals Inc. 8.1.5.1 Company overview 8.1.5.2 Financial performance 8.1.5.3 Product benchmarking
Follow Us:
8.1.5.4 Strategic initiatives 8.1.6 Fresenius Kabi AG 8.1.6.1 Company overview 8.1.6.2 Financial performance 8.1.6.3 Product benchmarking 8.1.6.4 Strategic initiatives 8.1.7 MEIJI HOLDING AND CO. 8.1.7.1 Company overview 8.1.7.2 Financial performance 8.1.7.3 Product benchmarking 8.1.7.4 Strategic initiatives 8.1.8 Mead Johnson & Company, LLC; 8.1.8.1 Company overview 8.1.8.2 Financial performance 8.1.8.3 Product benchmarking 8.1.8.4 Strategic initiatives 8.1.9 VICTUS, INC. 8.1.9.1 Company overview 8.1.9.2 Financial performance 8.1.9.3 Product benchmarking 8.1.9.4 Strategic initiatives About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers
Follow Us:
market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information – http://www.grandviewresearch.com/
Follow Us: